Investors making a wish list of stocks to watch should take a look at Altria Group, Inc. (NYSE:MO). The stock is offering a price-to-sales ratio of 4.83. This situation may create an opportunity where long term players can win with either market bounce, or when long-term value is realized. The broad Cigarettes industry has an average P/S ratio of 4.49, which is significantly better than the sector’s 6.21. In the past 13-year record, this ratio went down as low as 0.8 and as high as 7.68. Also, it is down from 74% of the total 43 rivals across the globe. MO traded at an unexpectedly high level on 11/28/2017 when the stock experienced a 2.04% gain to a closing price of $66.4. The company saw 9.63 million shares trade hands over the course of the day. Given that its average daily volume over the 30 days has been 6.91 million shares a day, this signifies a pretty significant change over the norm. Analysts are speculating a 20.48% move, based on the high target price ($80) for the shares that is set to reach in the next 12 months. The analysts, on average, are forecasting a $70.57 price target, but the stock is already up 10.65% from its recent lows. However, the stock is trading at -14.64% versus recent highs ($77.79). Analysts believe that we could see stock price minimum in the $59 range (lowest target price), allowing for another -11.14% drop from its current position. Leading up to this report, we have seen a 2.28% rise in the stock price over the last 30 days and a 4.06% increase over the past 3 months. Overall, the share price is down -1.8% so far this year. Additionally, MO had a day price range of $64.5 to $66.5. Heading into the stock price potential, Altria Group, Inc. needs to grow just 8.43% to cross its median price target of $72. In order to determine directional movement, the 50-day and 200-day moving averages for Altria Group, Inc. (NYSE:MO) are $64.88 and $68.08. Given that liquidity is king in short-term, MO is a stock with 1.91 billion shares outstanding that normally trades 0.62% of its float. The stock price recently experienced a 5-day gain of 0.87% with 0.98 average true range (ATR). MO has a beta of 0.64 and RSI is 60.47. Investors also need to beware of the Bristol-Myers Squibb Company (NYSE:BMY) valuations. The stock trades on a P/S of 4.9, which suggests that the shares are not attractive compared with peers. The broad Drug Manufacturers – Major industry has an average P/S ratio of 3.94, which is significantly better than the sector’s 5.42. In the past 13-year record, this ratio went down as low as 1.62 and as high as 7.25. Also, it is down from 68% of the total 756 rivals across the globe. Bristol-Myers Squibb Company by far traveled 35.88% versus a 1-year low price of $46.01. The share price was last seen 1.48% higher, reaching at $62.52 on 11/28/2017. At recent session, the prices were hovering between $61.61 and $62.96. This company shares are 1.49% off its target price of $63.45 and the current market capitalization stands at $102.47B. The recent change has given its price a -0.53% deficit over SMA 50 and -5.42% deficit over its 52-week high. The stock witnessed 4.3% gains, 6.22% gains and 15.89% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found BMY’s volatility during a week at 1.29% and during a month it has been found around 1.52%. Bristol-Myers Squibb Company (BMY) exchanged hands at an unexpectedly high level of 8.3 million shares over the course of the day. Noting its average daily volume at 5.51 million shares each day over the month, this signifies a pretty significant change over the norm. The market experts are predicting a 19.96% rally, based on the high target price ($75) for Bristol-Myers Squibb Company shares that is likely to be hit in the 52 weeks. Analysts anticipate that traders could see stock price minimum in the $49 range (lowest target price). If faced, it would be a -21.63% drop from its current position. Overall, the share price is up 6.98% year to date.